Comparative Analysis of Octreotide Long Acting Release (LAR) and Lanreotide in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Single Institution Experience

被引：0

作者：

Wu, S. ^{[1
]}

Reta-Impey, P. ^{[1
]}

Manivannan, N. ^{[1
]}

Tirumani, S. H. ^{[2
]}

Fu, P. ^{[3
]}

Cao, S. ^{[3
]}

Asa, S. ^{[4
]}

Kardan, A. ^{[2
]}

Liu, F.

Avril, N. ^{[2
]}

Wojtylak, P. ^{[2
]}

Lee, R. ^{[5
]}

Bajor, D. ^{[5
]}

Selfridge, E. ^{[5
]}

Saltzman, J. ^{[5
]}

Hardacre, J. ^{[6
]}

Ammori, J. ^{[6
]}

Winter, J. ^{[6
]}

Mohamed, A. ^{[5
]}

机构：

[1] Case Western Reserve Univ, Dept Internal Med, UH Seidman Canc Ctr, Cleveland, OH 44106 USA

[2] Case Western Reserve Univ, Dept Radiol, UH Seidman Canc Ctr, Cleveland, OH 44106 USA

[3] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA

[4] Case Western Reserve Univ, Dept Pathol, UH Seidman Canc Ctr, Cleveland, OH 44106 USA

[5] Case Western Reserve Univ, Div Hematol & Med Oncol, UH Seidman Canc Ctr, Cleveland, OH 44106 USA

[6] Case Western Reserve Univ, Div Surg Oncol, UH Seidman Canc Ctr, Cleveland, OH 44106 USA

来源：

PANCREAS | 2021年 / 50卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

C-11

引用

页码：448 / 449

页数：2

共 50 条

[1] The sequencing of lanreotide (LAN) after octreotide LAR (OCT) for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Saif, Wasif M.
Parikh, Rohan
Ray, David
Kaye, James A.
Kurosky, Samantha K.
Thomas, Katharine
Beveridge, Thomas
Mirakhur, Beloo
Lubeck, Catherine A.
Nagar, Saurabh P.
Soares, Heloisa
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[2] The Sequencing of Lanreotide (LAN) After Octreotide LAR (OCT) for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Saif, Wasif M.
Parikh, Rohan C.
Ray, David
Kaye, James A.
Kurosky, Samantha K.
Thomas, Katharine
Halfdanarson, Thorvardur R.
Beveridge, Thomas
Mirakhur, Beloo
Lubeck, Catherine A.
Nagar, Saurabh
Soares, Heloisa
[J]. PANCREAS, 2019, 48 (03) : 450 - 450
[3] Lanreotide vs. Octreotide-LAR for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): An Observational Time and Motion Analysis
Ryan, Pamela
McBride, Ali
Ray, David
Pulgar, Sonia
Ramirez, Robert
Elquza, Emad
Favaro, Justin
Dranitsaris, George
[J]. PANCREAS, 2019, 48 (03) : 450 - 450
[4] Lanreotide Autogel/Depot (LAN) Post-Octreotide Long-Acting Release (OCT) for Safe and Tolerable Treatment of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Saif, M. Wasif
Fu, Julie
Smith, Melissa
Maloney, Antonia
Relias, Valerie
JWeinstein, Barbara
Suarez, Yvelisse N.
Goodman, Martin D.
Daly, Kevin P.
[J]. PANCREAS, 2017, 46 (03) : 436 - 436
[5] Lanreotide Autogel/Depot (LAN) Post-Octreotide Long-Acting Release (OCT) for Safe and Tolerable Treatment of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
不详
[J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (12) : 12 - 13
[6] Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Kizilgul, Muhammed
Delibasi, Tuncay
[J]. TRANSLATIONAL GASTROINTESTINAL CANCER, 2015, 4 (01) : 39 - 56
[7] Real-World Comparative Analysis of Lanreotide and Octreotide Long-Acting Release (Lar) Use for Neuroendocrine Tumors (NETS) in Canada
Loree, Jonathan
Feuilly, Marion
Laforty, Callahan
Liovas, Anna
McKechnie, Heather
Cheung, Winson
[J]. PANCREAS, 2020, 49 (03) : 477 - 477
[8] Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) Preface
de Herder, Wouter W.
[J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2012, 26 (06) : 689 - 690
[9] Cutaneous Metastasis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-Nets)
Dhingra, Rohit
Tse, Julie Y.
Saif, Muhammad Wasif
[J]. JOURNAL OF THE PANCREAS, 2018, 19 (05): : 258 - 260
[10] Predictive Markers of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETS)
Issaeva, S.
Khalimova, Z.
Safarova, M.
Gumarova, A.
Yuldashev, A.
[J]. NEUROENDOCRINOLOGY, 2018, 106 : 89 - 89

← 1 2 3 4 5 →